Recovery Innovations

Recovery Innovations, based in Eatontown, NJ, is one of the SAMHSA-registered treatment programs operating in NJ. The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Recovery Innovations

On care levels specifically: The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. What that means in practice is that matching Recovery Innovations to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

Recovery Innovations accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. What tends to produce post-admission financial surprise is not the facility being out of network — it is the verbal assurance that did not make it into writing. Ask for the written VOB before admission, save the email, and the rest of the financial conversation becomes a lot simpler.

Specialty programming

The facility's documented specialty programming includes: Adult women, Adult men. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Three questions to put to Recovery Innovations before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Getting answers in writing protects against the downstream surprises.